CD40LG and COVID-19: When compared to their respective HD control groups, we found no IgM or IgG ALAb (Supplementary Figure S3), suggesting that IgM ALAb may not prevail for more than 6 months in mild cases of non-hospitalized COVID-19, although our sample size may have been too small to detect residual autoantibodies, especially in these mild non-hospitalized cases.